drugset / Trial / NCT06481592

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.

NCT06481592

Phase 2 Recruiting 60 enrolled Iovance Biotherapeutics, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial cancer.

Timeline

Start
2024-10-29
Primary completion
2028-05
Completion
2029-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Tumor Infiltrating Lymphocytes Cell therapy

Indications